NYSE:PL
NYSE:PLProfessional Services

Planet Labs (PL) valuation after strong earnings, guidance hike, and major government wins in Earth observation and AI

Planet Labs PBC (PL) just delivered a quarter that checked several important boxes for investors, with faster revenue growth, four straight quarters of adjusted EBITDA profit, and a guidance hike for fiscal 2026. See our latest analysis for Planet Labs PBC. The market has been quick to reward that progress, with the stock now at $18.24 and a blistering year to date share price return of 359.45 percent. The 1 year total shareholder return of 354.86 percent and 3 year total shareholder return...
NYSE:SR
NYSE:SRGas Utilities

Spire (SR) Valuation Check After 28% One-Year Gain and Premium Utility Pricing

Spire (SR) has quietly put together a solid run this year, with the stock up about 22% year to date and nearly 28% over the past year, easily outpacing many utilities peers. See our latest analysis for Spire. The latest move to around $83 per share builds on steady buying over recent months, with a 90 day share price return of about 9 percent and a one year total shareholder return above 28 percent. This suggests positive momentum rather than a speculative spike. If Spire’s run has you...
NYSE:RCUS
NYSE:RCUSBiotechs

Assessing Arcus Biosciences’ Valuation After Halting Key GI Trials and Pivoting to Casdatifan-Focused Strategy

Arcus Biosciences, Inc., has drawn fresh attention after scrapping its late stage STAR-221 and EDGE-Gastric trials in upper gastrointestinal cancers, a setback that also clarifies where the next wave of potential value may come from. See our latest analysis for Arcus Biosciences. The abrupt end to STAR-221 and EDGE-Gastric triggered a sharp reset in sentiment, with a 1 day share price return of minus 14.36 percent. Arcus still posts an 85.92 percent 3 month share price return and a 33.89...
NYSE:EAT
NYSE:EATHospitality

Brinker International (EAT): Assessing Valuation After Fresh Optimism From JPMorgan and Citigroup Reports

Brinker International (EAT) grabbed attention after upbeat reports from JPMorgan and Citigroup, as both firms pointed to effective cost cuts and stronger guest traffic as key drivers of renewed investor confidence. See our latest analysis for Brinker International. The upbeat commentary from JPMorgan and Citigroup lands at a time when momentum is clearly building, with a 1 month share price return of 27.62 percent helping push Brinker to $144.45 and supporting a 3 year total shareholder...
NasdaqGS:ASND
NasdaqGS:ASNDBiotechs

Can Ascendis Pharma Still Offer Value After 2025 Rally and Endocrinology Milestones?

If you are wondering whether Ascendis Pharma at around $220 a share is still good value after such a strong run, you are not alone. That is exactly what this breakdown is going to tackle. The stock has climbed 7.3% over the last week, 7.8% over the past month, and is up 59.7% year to date and 69.7% over the last year, signaling that market expectations and risk perceptions have shifted meaningfully. Recent headlines have focused on Ascendis progress in advancing and de-risking its...
NasdaqGS:PTC
NasdaqGS:PTCSoftware

Will AI-Driven PLM Wins in Autonomous EVs Change PTC's (PTC) Innovation-Led Narrative?

In recent days, PTC announced that HOLON, a BENTELER Group subsidiary, is using its Windchill+ SaaS PLM platform to develop an autonomous Level-4 electric vehicle and also launched its Arena AI Engine to automate document review, comparison, and compliance in PLM and QMS workflows. Together, these moves highlight PTC’s push to embed AI into cloud-based product lifecycle tools that underpin complex, highly regulated manufacturing projects like autonomous EVs. We’ll now examine how PTC’s...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Did FDA’s AVT05 Setback and Guidance Cut Just Shift Alvotech’s (ALVO) Investment Narrative?

Earlier in December 2025, law firm Hagens Berman began investigating Alvotech after the FDA issued a Complete Response Letter citing deficiencies at its Reykjavik manufacturing facility, prompting the company to sharply reduce its 2025 revenue and adjusted EBITDA guidance for its lead biosimilar candidate AVT05. This combination of regulatory setbacks and questions over prior disclosures highlights how central manufacturing quality and transparent guidance are to Alvotech’s biosimilar-led...
NasdaqGS:ADP
NasdaqGS:ADPProfessional Services

Is ADP’s Embedded Benefits Push Reshaping the Investment Case for Automatic Data Processing (ADP)?

In December 2025, ADP, Inc. integrated Thatch’s Individual Coverage Health Reimbursement Arrangement platform into its RUN Powered by ADP payroll system and launched the Save4Retirement Pooled Employer Plan, embedding health and retirement benefits directly into payroll workflows for small and mid-sized employers. Together, these moves highlight how ADP is deepening its role as a core infrastructure provider for outsourced HR, linking payroll with healthcare and retirement administration to...
NYSE:GPC
NYSE:GPCRetail Distributors

How Investors May Respond To Genuine Parts (GPC) Upgraded 2025 Revenue Outlook After Q3 Sales Growth

In October 2025, Genuine Parts Company reported third-quarter sales rising 4.9% year over year, supported by comparable sales growth and acquisitions across its global automotive and industrial parts network. The company also raised its full-year 2025 revenue growth outlook to 3–4%, signaling management’s confidence in execution despite a challenging macroeconomic backdrop. We’ll now explore how Genuine Parts’ upgraded full-year revenue outlook could shape its existing investment narrative...
NasdaqGS:GLBE
NasdaqGS:GLBEMultiline Retail

How Citizens’ Renewed Confidence in Global-E’s Shopify Partnership Will Impact Global-E Online (GLBE) Investors

Recently, Citizens reiterated its Market Outperform rating on Global-E Online, underscoring the company’s leadership in cross-border e-commerce and its strong relationship with Shopify as key strengths supporting its long-term business outlook. The report also highlighted Global-E’s healthy financial position and expanding merchant pipeline, suggesting that its role in a growing cross-border e-commerce market could reinforce confidence in its future earnings potential. Now, we’ll explore how...
NYSE:FIGS
NYSE:FIGSLuxury

What FIGS (FIGS)'s Earnings Beat and Olympic Push Means For Shareholders

FIGS recently reported third-quarter 2025 results that exceeded market expectations for both earnings per share and revenue, underscoring solid operating execution in its healthcare apparel business. Analysts have since highlighted FIGS' international expansion and upcoming Winter Olympics-linked marketing campaigns as potentially meaningful growth drivers for its direct-to-consumer model. We’ll now explore how FIGS’ stronger-than-expected quarterly performance could influence its existing...
NYSE:TNET
NYSE:TNETProfessional Services

Does TriNet Group’s (TNET) Higher Dividend Highlight Earnings Quality or Limited Reinvestment Ambition?

TriNet Group, Inc. recently announced that its Board of Directors approved a quarterly cash dividend of US$0.275 per share, with a record and ex-dividend date of January 2, 2026 and a payout date of January 26, 2026. This cash dividend underscores TriNet's ongoing emphasis on returning cash to shareholders, which may be an important signal about capital allocation priorities. We’ll examine how this newly declared US$0.275 per-share dividend influences TriNet’s investment narrative around...
NYSE:RDW
NYSE:RDWAerospace & Defense

Redwire (RDW) Is Up 14.1% After $44 Million DARPA Deal and Space Data Center Buzz - What's Changed

Earlier this month, Redwire Corporation presented at the 14th Annual ROTH Deer Valley Event, highlighting its $44 million DARPA Otter VLEO mission contract, the integration of Edge Autonomy, and recent facility expansion in Michigan. Investor attention is also being drawn to Redwire’s potential role in emerging space-based data center projects alongside existing partners Blue Origin and SpaceX, which could broaden its foothold in next-generation space infrastructure. Now we’ll examine how...
NasdaqCM:MLTX
NasdaqCM:MLTXBiotechs

MoonLake Immunotherapeutics (MLTX) Valuation After Sonelokimab Phase 3 Setback and Emerging Lawsuits

MoonLake Immunotherapeutics (MLTX) is back in the spotlight after disclosing that lead drug candidate sonelokimab fell short of a rival treatment in Phase 3 trials, triggering lawsuits and a brutal repricing of the stock. See our latest analysis for MoonLake Immunotherapeutics. The latest bounce to a share price of $14.79, reflected in a 1 month share price return of 15.82 percent, comes after a brutal 90 day share price collapse of 72.24 percent and a 1 year total shareholder return of...
NYSE:WM
NYSE:WMCommercial Services

The Bull Case For Waste Management (WM) Could Change Following Analyst Upgrades Ahead Of Earnings – Learn Why

In recent weeks, Waste Management has seen improving sentiment as analysts raised earnings estimates and projected year-over-year growth ahead of its upcoming results. Behind this optimism lies a view that the company’s near-term business health and profitability could strengthen, even as it contends with rising capital needs and margin pressures. We’ll now examine how this analyst optimism ahead of earnings might influence Waste Management’s investment narrative built around...
NasdaqGS:EXPO
NasdaqGS:EXPOProfessional Services

What Exponent (EXPO)'s Q3 Revenue Beat And Broad-Based Demand Mean For Shareholders

Earlier this month, Exponent, Inc. reported third-quarter revenues that grew 9.6% year on year and exceeded analyst expectations by 4%, crediting its diversified portfolio and broad industry reach. This performance marked the strongest analyst estimates beat among its peer group, underlining how Exponent’s cross-sector expertise is translating into resilient demand. Next, we’ll examine how Exponent’s double-digit net revenue growth and broad-based demand may influence its existing investment...
NYSE:SDRL
NYSE:SDRLEnergy Services

Reassessing Seadrill (NYSE:SDRL) Valuation After Citigroup’s Downgrade and Shift in Analyst Sentiment

Citigroup Downgrade Puts Fresh Scrutiny on Seadrill Citigroup's move to cut Seadrill (NYSE:SDRL) from Buy to Neutral, while trimming its outlook, has put fresh attention on a stock already down about 19% this year, despite improving fundamentals. See our latest analysis for Seadrill. The downgrade lands after a choppy run for Seadrill, with a roughly 5.6% 1 month share price return failing to offset a near 19% year to date share price decline. The 3 year total shareholder return remains...
NasdaqGS:ALLT
NasdaqGS:ALLTSoftware

Allot (ALLT): Assessing Valuation After Renewed Analyst Optimism and Earnings Upgrades

Renewed analyst optimism around Allot (ALLT), highlighted by its Zacks Rank of #1 Strong Buy and a sharply upgraded earnings outlook over the past 3 months, has pushed the stock sharply ahead of its tech peers. See our latest analysis for Allot. The optimism seems to be feeding directly into the tape, with Allot’s share price at $9.86 after a robust year to date share price return of around 59 percent and a standout 1 year total shareholder return of roughly 87 percent. This suggests momentum...
NYSE:NNN
NYSE:NNNRetail REITs

Will Upgraded Outlook for Occupancy and Acquisitions Change NNN REIT's (NNN) Narrative?

Recently, analysts upgraded NNN REIT on the back of its resilient triple-net retail portfolio, expectations for occupancy above 98% by year-end, and record-paced acquisition plans supported by about US$1.40 billion in liquidity and a BBB+ credit rating. An interesting angle is how NNN REIT’s rapid tenant turnarounds and consistent dividend growth record are reinforcing confidence in its ability to manage retail-sector risks while expanding its portfolio. We’ll now explore how this improved...
NasdaqGS:CART
NasdaqGS:CARTConsumer Retailing

How Investors Are Reacting To Maplebear (CART) Expanding AI Shopping And Same-Day Home Improvement Delivery

Earlier this month, Instacart announced it became the first grocery partner to launch an end-to-end shopping app on ChatGPT and separately expanded its same-day delivery offering through a new partnership with The Home Depot Canada across more than 175 stores. Together, these moves highlight how Instacart is using AI-driven customer experiences and broader retailer coverage, including big and bulky items, to deepen its role in everyday household and home improvement purchasing. We’ll now...
NYSE:AZO
NYSE:AZOSpecialty Retail

Do AutoZone’s (AZO) Rising Sales But Softer Earnings Recast Its Store Expansion Strategy?

AutoZone, Inc. has reported past first-quarter 2025 results, with sales rising to US$4,628.63 million while net income and earnings per share declined year over year. The combination of higher revenue but lower profitability, alongside management’s commitment to opening more locations, highlights both growth ambition and cost pressures. We’ll now examine how AutoZone’s higher sales but softer earnings shape its investment narrative and the outlook for continued store expansion. Rare earth...
NasdaqGS:CCOI
NasdaqGS:CCOITelecom

Assessing Cogent Communications Holdings (CCOI) Valuation After Ongoing Insider Share Sales by Its CFO

Insider selling puts fresh focus on Cogent Communications Holdings Cogent Communications Holdings (CCOI) is back on investors radar after Chief Financial Officer Thaddeus Weed sold 7,300 shares on December 11, extending a year long pattern of insider selling without any offsetting purchases. See our latest analysis for Cogent Communications Holdings. The latest CFO sale lands against a volatile backdrop. Cogent’s 7 day share price return of 18.6 percent and 30 day share price return of 32.6...
NYSE:OSK
NYSE:OSKMachinery

Oshkosh (OSK): Evaluating Whether Recent Share Price Gains Still Leave Undervalued Upside Potential

Oshkosh (OSK) has been quietly rewarding patient investors, with the stock climbing about 6% over the past month and more than 40% year to date, driven by solid revenue and earnings growth. See our latest analysis for Oshkosh. That momentum is not a flash in the pan. Oshkosh has delivered a robust year to date share price return, while a solid one year total shareholder return suggests investors are increasingly pricing in its earnings traction and defense exposure rather than backing...
NasdaqGS:BUSE
NasdaqGS:BUSEBanks

Will First Busey’s Expanded Share Repurchase Plan Reshape First Busey’s (BUSE) Capital Allocation Narrative

On December 4, 2025, First Busey increased its equity buyback authorization by 4,000,000 shares, bringing the total program to 11,666,667 shares. This expanded repurchase capacity highlights management’s willingness to return capital to shareholders and may signal confidence in the company’s underlying fundamentals. Next, we’ll explore how this enlarged buyback program shapes First Busey’s investment narrative, especially its approach to shareholder returns and capital allocation. Rare earth...